Draft:Know Labs

Know Labs Granted Patent for its Bio-RFID™ Technology

Retrieved on: 
Tuesday, April 7, 2020
Health, FDA, Medical devices, Diabetes, Technology, Hardware, Biotechnology, Automatic identification and data capture, Privacy, Radio-frequency identification, Ubiquitous computing, Wireless, Draft:Know Labs

Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced that it has been granted a patent on its Bio-RFID technology.

Key Points: 
  • Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced that it has been granted a patent on its Bio-RFID technology.
  • Phil Bosua, Know Labs CEO and inventor of the Bio-RFID technology, said, We are extremely pleased and proud to obtain this patent.
  • Know Labs first focus with its Bio-RFID technology is the wearable non-invasive continuous monitoring of blood glucose levels, an important breakthrough for the diabetes community.
  • As a platform technology, the monitoring of blood glucose is the first of many diagnostics Know Labs will pursue.

Know Labs Formally Announces its YouTube Channel

Retrieved on: 
Wednesday, January 29, 2020
Diabetes, Health, Medical devices, OTC Markets Group, YouTube, Software, World Wide Web, Digital media, Draft:Know Labs

Know Labs, Inc. (OTCQB: KNWN) today formally announced the Know Labs YouTube Channel.

Key Points: 
  • Know Labs, Inc. (OTCQB: KNWN) today formally announced the Know Labs YouTube Channel.
  • The Know Labs YouTube Channel can be found at: www.youtube.com/c/KnowLabs .
  • In a new posting today, Know Labs CEO Phil Bosua outlined advances made in the laboratory over the past 90 days.
  • Know Labs, Inc. is a public company whose shares trade under the stock symbol KNWN.

Know Labs Unveils New UBAND Design and Smartphone App

Retrieved on: 
Thursday, November 21, 2019
Diabetes, Health, Consumer electronics, Technology, Software, Medicine, Blood tests, Activity trackers, Medical technology, Clinical medicine, Medical monitoring, Continuous glucose monitor, Blood glucose monitoring, CGM, Diabetes, Draft:Know Labs, Nightscout

Know Labs, Inc. (OTCQB: KNWN) unveiled today a first look at its wearable UBAND Continuous Glucose Monitor (CGM) along with its companion iPhone App.

Key Points: 
  • Know Labs, Inc. (OTCQB: KNWN) unveiled today a first look at its wearable UBAND Continuous Glucose Monitor (CGM) along with its companion iPhone App.
  • View the full release here: https://www.businesswire.com/news/home/20191121005261/en/
    Know Labs unveils new UBAND design and smartphone app (Photo: Business Wire)
    Phil Bosua, Know Labs CEO and creator of the UBAND, said, We are making great progress in developing our wearable non-invasive continuous glucose monitor that will improve the lives of people with diabetes and pre-diabetes worldwide.
  • Know Labs plans to come to market with its wearable non-invasive UBAND CGM subsequent to FDA approval.
  • The UBAND CGM will connect to its smartphone App via Bluetooth and will feature a 7-day battery life.

Know Labs Announces Technology Webcast

Retrieved on: 
Tuesday, September 24, 2019
Biotechnology, Hardware, Health, Diabetes, Medical devices, Technology, Medicine, Blood glucose monitoring, Medical monitoring, Clinical medicine, Draft:Know Labs

Know Labs, Inc. (OTCQB: KNWN) a creator and provider of diagnostic solutions, announced the publication of a webcast hosted by BioPub, a biotech investment discussion website found at www.biopub.co .

Key Points: 
  • Know Labs, Inc. (OTCQB: KNWN) a creator and provider of diagnostic solutions, announced the publication of a webcast hosted by BioPub, a biotech investment discussion website found at www.biopub.co .
  • Participants from Know Labs were Phil Bosua, CEO, Ron Erickson, Chairman and Dr. James Andy Anderson, Chief Medical Officer.
  • The webcast included an overview of the Know Labs technology and a question and answer session.
  • In addition to discussing the Know Labs technology and its application in a wearable as a non-invasive continuous glucose monitor and other applications, the Company discussed its current financing the details of which can be located on www.flashfunders.com/knowlabs .